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Abstract: Background. The main concern in the treatment of
laryngeal carcinomas is tumor control with preservation of laryn-
geal functions. We believe that salvage supracricoid partial lar-
yngectomy (SPL) should be carefully considered in selected
cases of radiotherapy failure, because it can offer the possibility
of achieving adequate tumor control with preservation of laryn-
geal functions.
Methods. A series of 31 patients who underwent an SPL as
salvage procedure after radiotherapy failure was reviewed.
Results. Locoregional control rate was 75%, with 60% 5-
year overall survival; no patients were lost to follow-up, and a
death-from-disease rate of 19.35% was recorded. Restoration of
laryngeal functions was achieved in 89.29% of the patients. No
statistically signiﬁcant differences were found in locoregional
control regarding anterior commissure involvement, elective
neck dissection versus wait-and-see policy, pathologic positive
neck disease, and restage I–II versus restage III–IV.
Conclusion. The oncologic and functional results indicate
the consistency of salvage SPL, proposing this type of operation
as a serious alternative to total laryngectomy in carefully
selected cases. VC 2008 Wiley Periodicals, Inc. Head Neck 30:
1064–1071, 2008
Keywords: partial laryngectomy; salvage surgery; larynx carci-
noma; radiation failure; neck dissection
The main concern in the treatment of laryngeal
carcinomas is tumor control with preservation of
whole laryngeal functions.
Early laryngeal cancer can be effectively
treated either by larynx preserving surgery or
with external beam radiation therapy; results in
terms of tumor control and preservation of func-
tion for both modalities are satisfactory with
reported rates of recurrence or persistence of tu-
mor varying from 10% to 35%.1–6
On the other hand, if a local recurrence occurs
after radiation therapy, then surgery is manda-
tory and remains the only available tool to achieve
local control. Total laryngectomy is still consid-
ered in most centers the standard treatment for
radiotherapy failures. Nevertheless, in selected
cases, partial surgery with the attempt to pre-
serve laryngeal function can be considered.
Recent reports in the literature did put in evi-
dence that postradiotherapy supracricoid partial
laryngectomy (SPL) is a valid alternative to total
laryngectomy in selected cases.7–11 SPL can be a
safe option from the oncological point of view and,
at the same time, is a valuable solution from the
functional point of view, offering to patients a
chance to control the disease and to retain the
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laryngeal functions even in radiation therapy fail-
ures, so that those patients will not experience the
full range of functional impairments that follow
total laryngectomy.
To understand if salvage SPL represents a
valid alternative to total laryngectomy in selected
cases, we critically reviewed our direct experience
on this subject by means of a retrospective analy-
sis of a 20-year period.
This paper presents a series of 31 radiation
failures treated with SPL in 2 Italian institutions,
particularly focusing on the oncological and func-
tional results.
MATERIALS AND METHODS
From a joined database of the Otolaryngology
Department of the University of Florence and the
OtolaryngologyDepartment of theHospital ‘‘Fate-
benefratelli’’ in Rome, accounting for 289 patients
who underwent a salvage surgical procedure
between June 1986 and January 2005 for laryn-
geal recurrence following elective radiotherapy
treatment, the authors identiﬁed 31 consecutive
patients (10.73%) who underwent SPL as a sal-
vage procedure. The remaining 258 patients were
treated with different modalities: 226 total lar-
yngectomies (78.20%), 12 cordectomies in laryng-
oﬁssure (4.15%), 12 transoral endoscopic laser
excisions (4.15%), 4 endoscopic nonlaser resec-
tions (1.38%), and 4 fronto-lateral laringectomies
(1.38%).
The series included 29 men and 2 women, with
age varying between 40 and 72 years (mean, 60.1
years).
Pretreatment TNM staging was corrected
using the 2002 6th edition12 based on the clinical
records available.
An overview of the clinical series is shown in
Table 1.
Before treatment with radiotherapy, 2 patients
were initially seen with Tis glottic lesion, 11 with
T1a carcinoma, 12 with T1b, 4 with T2 glottic can-
cer, and 2 with T2 supraglottic carcinoma. Disease
in all patients was clinically classiﬁed as N0, so
that the series had 2 patients with stage 0 disease,
23 patients with stage I, and 6 patients with stage
II. All tumors were biopsy-proven squamous cell
carcinomas.
Patients were treated with curative radiation
therapy; the total laryngeal dose per patient
ranged from 65 to 70 Gy (mean, 66 Gy) fractio-
nated over a period of 6 to 7 weeks. In the 6
patients seen with T2 laryngeal carcinoma, the
clinical target volume was extended to include
neck lymphatic areas of levels II–IV with a dose of
50 Gy.
Disease-free interval ranged between 2 and 47
months (mean, 13 months); 3 patients were seen
with a recurrence within the ﬁrst 4 months (2 of
them showed a recurrence after only 2 months,
which probably was actually a persistence of the
disease more than a true recurrence), 12 patients
experienced a recurrence between 5 and 12
months, 12 patients between 13 and 24 months, 4
patients after 2 years.
All radiotherapy failures were biopsy proven;
the extension of the disease was assessed by con-
trast-enhanced CT scan of the neck and by direct
microlaryngoscopy with rigid telescopes at 08, 308,
and 708 under general anesthesia. Pulmonaryme-
tastases were ruled out with thoracic CT scan;
pulmonary and cardiac functional tests were sat-
isfactory in all cases.
In 10 patients with recurrent tumors, the
restaging after radiotherapy was unchanged,
while in the remaining 21 patients an upstaging
was recorded (67%): in 2 patients we had a pro-
gression from stage 0 to stage II, in 10 patients
from stage I to stage II, in 7 patients from stage I
to stage III, and in 2 patients from stage II to stage
III.
Institutional Review Board allowance was
requested and obtained by the local committee.
All 31 patients agreed to the procedure and signed
an informed consent form. SPL with cricohyoid-
pexy (CHP) was performed in 23 cases while the
remaining 8 patients underwent SPL with crico-
hyoidepiglottopexy (CHEP).
Neck dissection was performed in 16 cases,
homolateral elective selective neck dissection
(SND) of levels II–IV was performed in 11 N0
patients, a therapeutic homolateral functional
neck dissection of levels II–V was performed in 5
patients clinically N1, and in 1 of them, who was
seen with a rT3N1 tumor with supraglottic exten-
sion, a contralateral SND II–IVwas carried out.
Charts were reviewed with particular atten-
tion to clinical conditions considered to have an
impact in terms of prognosis and restoration of
function. Initial clinical tumor stage before radio-
therapy, ﬁeld of irradiation, clinical and patho-
logic restage of the recurrence, anterior commis-
sure involvement, thyroid cartilage inﬁltration at
pathologic examination, supraglottic extension,
elective neck dissection, neck disease, arytenoid
involvement, and type of supracricoid surgery
(CHP vs CHEP) were tested for impact on loco-
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regional control. Arytenoid resection, a type of
supracricoid surgery (CHP vs CHEP), and the
adjunction of elective neck dissection were tested
in terms of functional results based upon time of
decannulation and time of oral intake restoration.
The statistical analysis was performed with an
IBM computer using STATA (Stata Corporation,
College Station, TX).
Considering the day of the salvage surgery as
the starting day of the observation, follow-up was
for a minimum of 2 years or until death (mean, 45
months; minimum 6, maximum 180). Follow-up
end points included evidence of local or regional
recurrence, death from disease, and death from
other causes. No patients were lost to follow-up.
Overall survival was calculated using the
Kaplan–Meier method, considering the day of sal-
vage partial laryngectomy as the starting day of
the observation and death from any cause as the
endpoint. Locoregional control was calculated
using the Kaplan–Meier method, considering the
day of salvage partial laryngectomy as the start-
Table 1. Overview of the clinical series.
cTNM rTNM rpTNM
Surgery and neck
dissection type (if present) Results
T1b N0 T2 N0 T2 N0 CHEP 1 SND (II–IV) NED at 41 mo
T1a N0 T2 N0 T2 N0 CHEP 1 SND (II–IV) NED at 54 mo
T2 N0 T3 N1 T3 N1 CHP 1 FND (II–V) NED at 23 mo
T1a N0 T3 N1 T3 N1 CHP 1 FND (II–V) NED at 23 mo
Tis N0 T2 N0 T3 N1 CHP 1 SND (II–IV) Arytenoid 1 esophagus recurrence at 4 mo; after TL
with esophagectomy and gastric pull-up, patient died
from pulmonary metastases
T1b N0 T2 N0 T4 N1 CHEP 1 SND (II–IV) NED at 35 mo
T1b N0 T3 N1 T4 N1 CHP 1 FND (II–V) 1 SND (II–IV) NED at 37 mo
T1b N0 T3 N0 T3 N0 CHP 1 SND (II–IV) NED at 50 mo
T1a N0 T2 N0 T2 N0 CHEP 1 SND (II–IV) NED at 60 mo
Tis N0 T2 N0 T2 N0 CHEP 1 SND (II–IV) NED at 60 mo
T2 N0 T3 N1 T4 N1 CHP 1 FND (II–V) Arytenoid recurrence at 9 mo; after TL, NED at 48 mo
T1a N0 T3 N1 T3 N1 CHP 1 FND (II–V) NED at 60 mo
T1b N0 T2 N0 T2 N0 CHP 1 SND (II–IV) NED at 45 mo
T1b N0 T2 N0 T2 N0 CHP 1 SND (II–IV) NED at 41 mo
T1a N0 T2 N0 T2 N0 CHP 1 SND (II–IV) NED at 30 mo
T1b N0 T3 N0 T3 N1 CHP 1 SND (II–IV) NED at 24 mo
T1a N0 T3 N0 T3 N0 CHP NED at 37 mo
T2 N0 T2 N0 T2 N0 CHP NED at 80 mo
T1b N0 T2 N0 T2 N0 CHP Cricoid recurrence after 4 mo; TL performed but patient
dies after another 2 mo
T1a N0 T1b N0 T1b N0 CHP Second T3 cancer of the piriform sinus after 43 mo; total
pharyngolaryngectomy performed with RT. Patient
dies from unresectable neck metastases after 62 mo
T1a N0 T2 N0 T2 N0 CHP Patient develops neck metastases after 6 mo and
receives neck dissection with postoperative RT. After
12 mo, patient dies from a new neck recurrence
T1b N0 T2 N0 T1b N0 CHP Patient develops neck metastases after 6 mo and
treated with chemo. Patient dies after 20 mo
T1b N0 T1b N0 T1b N0 CHP NED at 65 mo
T1a N0 T1b N0 T1b N0 CHEP NED at 30 mo
T1a N0 T3 N0 T3 N0 CHP Patient receives total laryngectomy for an ab ingestis
pneumonia. NED at 60 mo
T2 N0 T2 N0 T2 N0 CHP NED at 85 mo
T1b N0 T1b N0 T1b N0 CHEP NED at 60 mo
T2 N0 T2 N0 T2 N0 CHP NED at 41 mo
T1a N0 T1a N0 T2 N0 CHP Patient dies after 50 mo from vesical cancer
T1b N0 T1b N0 T1b N0 CHP NED at 44 mo
T2 N0 T2 N0 T2 N0 CHEP Tracheal recurrence at 14 mo; treated with chemo.
Patient dies after 19 mo
Abbreviations: cTNM, clinical TNM staging of the original neoplasia, prior to radiotherapy; rTNM, clinical TNM staging of the postradiotherapy relapse,
prior to salvage surgery; rpTNM, histopathologic TNM staging of the postradiotherapy relapse; CHEP, crico hyoid epiglotto pexy; SND, selective neck
dissection (followed by the resected levels); NED, no evidence of disease; CHP, crico hyoid pexy; FND, functional neck dissection (followed by the
resected levels); TL, total laryngectomy; RT, radiotherapy; chemo, chemotherapy.
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ing day of the observation and the reoccurrence of
local or neck disease as endpoint. The impact of
the reviewed clinical features in terms of locore-
gional control was analyzed using the Kaplan–
Meier curves; the difference between groups was
compared using the log-rank test. Probability val-
ues less than .05 were considered statistically sig-
niﬁcant.
RESULTS
The pathologic examination showed a further
upstaging in 5 cases, a downstaging in 1 case, and
a pathologic conﬁrmation of the clinical restaging
for the remaining 25 patients.
An overall complication rate of 16.13% was
recorded. No perioperative or postoperative mor-
tality occurred, but major complications occurred
in 3 cases (9.67%): 1 patient, who had been
treated with a CHP, had to undergo a total laryn-
gectomy because of severe postoperative aspira-
tion, and no tumor was found in the specimen; in 2
other patients, the development of a salivary ﬁs-
tula required a surgical revision, with direct clo-
sure of the pharyngeal opening in 1 case and with
closure with a pectoralis major ﬂap in the other
case; in both patients the larynx was preserved.
Minor complications occurred in 2 patients
(6.45%) that suffered of a cervical wound infection
that healed withmedical care.
In the series, 3 patients underwent a totaliza-
tion of the laryngectomy because of oncologic rea-
sons (see Table 1), so that functional results were
calculated among the remaining 28 patients: in
25, a complete restoration of laryngeal function
was achieved (89.29%), 1 patient received a total
laryngectomy because of aspiration pneumonia,
in 1 case decannulation never succeeded, and 1
patient had to retain a permanent gastrostomy to
compensate unsatisfactory oral intake.
The mean time for decannulation was 27 days
(range, 14–59 days), and the mean time for oral
intake restoration was 30 days (range, 12–72
days). The frequency of arytenoid resection is of-
ten felt to be an important factor in the restoration
of function; in our series, we resected 1 arytenoid
in 11 cases, while both arytenoids were preserved
in the remaining 20 patients. No differences in
terms of decannulation or restoration of oral
intake were noticed between the 2 groups; how-
ever, we did identify a subgroup of patients (6
cases) in which we recorded a prolonged decannu-
lation time (mean value, 40 days) with normal
oral food intake restoration time. These 6 patients
received a CHEP with preservation of both aryte-
noids. Other factors were evaluated in terms of
restoration of laryngeal function, and no differen-
ces were noticed related to type of laryngectomy
(CHP vs CHEP) and no neck dissection versus
monolateral or bilateral neck dissection.
According to the Kaplan–Meier method,
locoregional control rate was 75%, with 60% 5-
year overall survival percentage (Figures 1 and 2).
No statistically signiﬁcant differences (p >.05)
were found in locoregional control with regard to
anterior commissure involvement, elective neck
dissection versus wait-and-see policy, pathologic
positive neck disease, restage I–II versus restage
III–IV, thyroid cartilage inﬁltration at pathologic
examination, supraglottic tumor extension, aryte-
noid involvement, and type of supracricoid sur-
FIGURE 1. Kaplan–Meier 5-year locoregional control for sal-
vage supracricoid partial laryngectomy; falls in the curve repre-
sent appearance of relapse. Seventy-ﬁve percent of the patients
were disease-free at the end of the observation.
FIGURE 2. Kaplan–Meier 5-year overall survival for salvage
supracricoid partial laryngectomy. Falls in the curve reﬂect
deaths by any cause during the observation period. Sixty per-
cent of patients lived past the end of the follow-up time.
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gery (CHP vs CHEP). In Figure 3, we present the
most signiﬁcant ones.
Concerning neck results in the 31 patients
with recurrences that had been originally staged
N0 before radiotherapy, 5 patients were seen with
a N1 neck disease, whereas the remaining 26
were restaged N0. Neck dissection was performed
in the 5 N1 patients and in 11 N0 patients,
whereas 15 patients were admitted to a wait-and-
see policy. Occult neck metastasis at pathologic
examination of the specimen was found in 3 cases;
furthermore, in the wait-and-see group, 2 patients
developed a recurrence in the neck without any
evidence of local relapse or second primaries, so
we can suppose that they were seen with an occult
neck disease at the time of surgery, which subse-
quently turned into a clinical neck recurrence.
Thus, in our series, the rate of occult neck metas-
tasis in patients with N0 recurrent tumors after
radiotherapy is 5 of 26 (19.23%) (Figure 4).
A locoregional failure occurred in 7 patients
(Table 1).
Four patients were seen with a local relapse, 1
patient developed a second primary after 4 years,
and the remaining 2 patients had a relapse in the
neck.
A second salvage surgery was attempted in 5
of 7 failures: 2 patients underwent a total laryn-
gectomy, 1 patient had total laryngectomy with
total pharyngectomy, 1 patient a total laryngec-
tomy with total pharyngectomy and total esopha-
gectomy, and 1 patient had a neck dissection with
postoperative radiation on the neck.
The second salvage surgery was effective only
in 1 case in which a local recurrence at the aryte-
noid level was successfully treated with total
FIGURE 3. No statistical signiﬁcance was found in locoregional control regarding anterior commissure involvement, neck dissection,
pathological nodal status, or advanced restage. Endpoint of observation was Jan 2005.
FIGURE 4. Overview of the clinical series for what concerns
neck ﬁndings. Among 26 N0 patients, we found occult neck dis-
ease in 3 patients of the electively dissected group and 2 neck
recurrences developed in the wait-and-see group: 19% occult
neck disease rate.
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laryngectomy, and for the remaining 4 cases the
mean survival time after the second salvage pro-
cedure was 10months.
DISCUSSION
The optimal management of a laryngeal recur-
rence after radiotherapy should guarantee a safe
tumor clearance with organ preservation that
enables the patients to preserve speech, to allow a
normal oral alimentation, and to avoid a perma-
nent tracheostomy.
As a general rule, it has been for a long time
postulated that in a previously irradiated larynx,
if a partial laryngectomy is attempted, the inci-
dence of surgical complications is extremely high,
so that any form of laryngeal preserving operation
should be discouraged. This rule arises from the
evidence that the irradiated laryngeal tissues,
and almost the entire laryngeal cartilaginous
framework, eventually suffer from a consistent ﬁ-
brosis and hypovascularization that would pre-
vent the possibility of performing any sort of par-
tial laryngectomy without risking a fearsome con-
dritis, the occurrence of salivary ﬁstulas, pexy
disruption, or other local infection. All these com-
plications will inmost cases result in an important
detriment of the laryngeal functions so that in
most cases a total laryngectomy has to be per-
formed anyhow.13
Our series of 31 patients accounts for the
10.73% of the 289 surgical salvage procedures for
radiotherapy laryngeal failures performed in the
institutions conducting the study. However, if we
look at the distribution in time of salvage SPL, it
is interesting to notice that during the ﬁrst
10 years of observation (period: 1986–1995) over a
total of 160 radiotherapy failures, 134 (83.75%)
received a salvage total laryngectomy, 10 (6.25%)
a salvage SPL, and 16 (10%) patients were treated
with other surgical procedures; in the following
10 years of observation (period: 1996–2005) over a
total of 129 radiotherapy failures, 92 (71.31%)
received salvage total laryngectomy, 21 (16.27%)
a salvage SPL, and 16 (12.40%) were treated with
other surgical procedures. These data reﬂect that,
even if salvage SPL still remains indicated only
for a minority of cases, its frequency has more
than doubled in the last 10 years.
Total laryngectomy for salvage in cases of early
laryngeal cancers after radiotherapy achieves
local control in 78% to 85% of cT1 (preradio-
therapy staging) and 65% of cT2 (preradiotherapy
staging) glottic failures, and 40% to 55% of cT1–2
(preradiotherapy staging) supraglottic irradiation
failures,14–18 but total laryngectomy is not free
from complications. Pharyngocutaneous ﬁstulas,
wound infections, chyle leak, swallowing, and air
problems have been reported as complications of
total laryngectomy, with overall complications
rates of 20% to 40%.19,20 The incidence of phar-
yngocutaneous ﬁstula is reported to be as high
as 15% to 20%, while that of severe complica-
tions (carotid rupture, major wound break-
down, severe pharyngeal-esophageal stricture) is
10%.20,21
We must consider, however, that in the group
of salvage total laryngectomies, surgeons deal
with more locoregionally extended recurrences
that require extensive demolitions, and often the
recurrent disease presents after chemoradiation,
which signiﬁcantly increases the rate of surgical
complications.19
If the recurrent tumor is locally limited, a
transoral CO2 laser excision could be a valid
option in experienced hands22; however, local con-
trol rate after 1 surgical session is reported by
Steiner et al to be only of 38% and local control of
71% is reached after repeated laser surgery proce-
dures.
In two-thirds of the cases of our series, a recur-
rence was seen with a more advanced stage than
the original tumor; however, all of them were suit-
able for a salvage SPL. Clinical restaging of recur-
rent tumors is particularly difﬁcult, and a precise
and careful assessment by means of endoscopy
and imaging is required.
General and speciﬁc indications and contrain-
dications for SPL as salvage surgery do not differ
from those in nonirradiated tumors and are
already mentioned in other papers.13,23 Selection
is the key to success, and the patient should be
informed about the possibility of an intraoperative
conversion of the partial laryngectomy into a total
laryngectomy for oncological reasons. Submucosal
subtle tumor spread is a fearsome clinical feature
of recurrent squamous cell carcinomas after radio-
therapy so that a meticulous assessment of the
key points (crico-arytenoid joint, interarytenoid
tissue, subglottic margin) with frozen sections
during surgery is mandatory. Furthermore, we
believe that if the deﬁnitive pathologic examina-
tion of the specimen does not comport with
adequate tumor radicality, a completion of the lar-
yngectomy is advisable.
The overall complication rate in this series
(16.13%) is acceptable, demonstrating that SPL
as salvage surgery is feasible.
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We believe that some technical accuracy dur-
ing surgery is helpful to decrease postoperative
complications. After elevation of the subplatysma
apron ﬂap, we routinely suture a compress soaked
with cool Ringer solution to cover the entire inner
surface of the skin ﬂap to prevent vascular prob-
lems caused by excessive drying of irradiated tis-
sues. Furthermore, it is important to detach the
infrahyoid muscles from the hyoid bone in an ‘‘en
bloc’’ manner so that the entire bloc of the strap
muscles together with the thyroid isthmus is sep-
arated from the larynx and dissected downward,
respecting as much as possible the vascular sup-
ply coming from the superior and inferior thyroid
arteries and veins. This surgical step does not
interfere with the radicality of the neck dissection.
These infrahyoid musculo-glandular structures
will provide an enforcement cover to the pexy with
the intent to prevent disruptions.
The fact that the entire thyroid cartilage (with
the only exception of the inferior cornua to protect
the recurrent laryngeal nerves) is removed
decreases the incidence of condritis when com-
pared with salvage vertical partial laryngecto-
mies or salvage supraglottic laryngectomies. In
SPL, the remaining cartilages are the cricoid and
1 or both arytenoids that should not be subperi-
condrially exposed.
Pellini et al did analyze postoperative compli-
cations and functional results, comparing 65
patients treated with SPL with 17 patients who
received salvage SPL for radiotherapy failure.
They found no statistically signiﬁcant differences
between the 2 groups in terms of postoperative
complications, decannulation time, and restora-
tion of oral intake.24
In our series, functional results were subjec-
tively evaluated: in 89.29% of the cases, decannu-
lation, restoration of oral intake, and satisfactory
voice production that allowed normal social inter-
actions were achieved.
In 2002, Rifai et al25 presented a series of 37
radiotherapy failures that were treated with a
supracricoid laryngectomy (either CHP or CHEP)
and stated that preservation of both arytenoids
made recovery of laryngeal functionmuch easier.
In our series, we found no differences in terms
of time of decannulation and oral intake restora-
tion between patients with both arytenoids pre-
served versus those with 1 residual arytenoid.
These functional results highlight the possibility
of resecting 1 arytenoid for oncologic reasons
without jeopardizing oral intake restoration. It is
interesting to notice that the preservation of both
arytenoids while performing a CHEP has been
found to be related to prolonged decannulation
time, which might be connected with edema of
both arytenoids and of the residual epiglottis
resulting in transient laryngeal inlet stenosis.
Our functional results match data reported in
literature, in which functional outcome of SPL
seems not to differ in irradiated patients com-
pared with previously untreated cases.
Furthermore, we did not record a higher inci-
dence of complications and functional problems in
the group that underwent a neck dissection when
compared with the wait-and-see group.
The oncologic results, with 75% of locoregional
control rate and an organ preservation rate of
90%, indicate the consistency of salvage SPL, pro-
posing this type of operation as a serious alterna-
tive to total laryngectomy in carefully selected
cases. A critical analysis of our series reveals that
6 patients (19.35%) did die of cancer relapse (see
Table 1): among them 2 patients died from neck
disease, 1 patient developed a second primary
hypopharyngeal carcinoma at 43months from sal-
vage SPL, and the remaining 3 patients (9.68%)
died of a local relapse and might have beneﬁted
from a salvage total laryngectomy instead of the
SPL they received.
The role of elective neck treatment in conserv-
ative laryngeal salvage surgery after radiother-
apy for N0 recurrent tumors is still controversial.
In our series, the criteria to perform an elective
neck treatment were mostly subjective so that we
tried to gain from our data some helpful informa-
tion for future treatment strategies; we had a 67%
rate of upstaged recurrences, occult neck disease
rate was found to be 19.23% and always in
upstaged recurrences.
To understand the impact of elective neck radi-
ation therapy on neck relapses, we looked at the
radiation therapy ﬁeld. The initial radiotherapy
ﬁeld in the 5 N01 recurrences included the larynx
only (1 patient had Tis, 1 had T1a, and 3 had T1b),
for what concerns the restaging all 5 of them
showed an upstaged laryngeal cancer (4 patients
turned into a rT2 and 1 turned into a rT3).
We also looked at the 6 T2 cancers in which the
radiation ﬁeld included levels II–IV: all of them
were again restaged as T2, and 2 of them were
seen with N1 neck disease despite elective neck
irradiation. This suggests that, despite an
adequate elective radiation in the neck, the radio-
therapy does not prevent neck metastasis in
recurrent T2 tumors, even if in our series these
metastases were all clinically evident and no
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occult neck disease developed in the remaining 4
N0 patients that were admitted to a wait-and-see
protocol.
Locoregional control did not differ statistically
between the 2 groups (wait-and-see and electively
dissected group); however, we did not experience a
higher complication rate in the dissected group,
and, furthermore, in the wait-and-see group, we
were unable to control 2 relapses in the neck.
These ﬁndings suggest that in T2–3 upstaged
recurrences, even if the neck was electively irradi-
ated, an SND of level II–IV is advisable.
CONCLUSION
SPL is a feasible, oncologically safe, functionally
valid alternative to total laryngectomy in selected
laryngeal recurrences after radiotherapy.
The overall complication rate in this series is
comparable to that with other salvage surgical pro-
cedures. Selection is the key to success, and the
conversion to a total laryngectomy has to be done
whenever any doubt exists about the adequacy of
resection margins or if required by serious func-
tional problems. Ipsilateral elective neck dissec-
tion of levels II–IV is advisable in T2–3 upstaged
recurrences. Prognosis of second recurrences after
salvage surgery remains poor even after adequate
surgical resection.
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